Smartlens, a clinical-stage ophthalmic technology company in Sunnyvale, closed a $5.2M bridge funding round led by Ambit Health Ventures with participation from Graphene Ventures, Boutique Venture Partners, Harvard Business School Alumni Angels GNY and a group of eye care providers. The proceeds will support advancement of its next-generation glaucoma management devices.
Comments
Want to join the conversation?
Loading comments...